Linarol 5 MG


Linarol 5 MG


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)






Linagliptin is shown within the treatment of sort 2 diabetes mellitus to make strides glycaemic control in adults.

As monotherapy: in patients insufficiently controlled by eat less and work out alone and for whom metformin is improper due to narrow mindedness or contraindicated due to renal impairment.
As combination treatment: in combination with metformin when slim down and exercise plus metformin alone don’t give satisfactory glycaemic control in combination with a sulphonylurea and metformin when slim down and work out plus dual treatment with these therapeutic items don’t give satisfactory glycaemic control.



Linagliptin is shown to move forward glycemic control in patients with sort 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), an chemical that corrupts the incretin hormones GLP-1 (glucagon like peptide-1) and GIP (glucose subordinate insulinotropic polypeptide). Hence, Linagliptin increments the concentrations of dynamic incretin hormones, fortifying the discharge of affront from pancreatic beta (β) cells in a glucose-dependent way and diminishing the emission of glucagon from pancreatic alpha (α) cells within the circulation.


Dosage and Administration

Linagliptin 5 mg once every day. In case included to metformin, the measurements of metformin ought to be kept up and linagliptin managed concomitantly. When utilized in combination with a sulfonylurea, a lower measurements of the sulphonylurea may be considered to diminish the chance of hypoglycaemia.

Patients with renal disability: No dosage alteration required. Linagliptin can be taken with or without a feast at any time of the day.



Linagliptin may be a frail competitive and a powerless to direct mechanism-based inhibitor of CYP isozyme CYP3A4, but does not repress other CYP isozymes. The chance for clinically important intelligent by other therapeutic items on linagliptin is moo and in clinical thinks about linagliptin had no clinically pertinent impact on the pharmacokinetics of metformin, glyburide, simvastatin, warfarin, digoxin or verbal contraceptives.



Touchiness to the dynamic substance or to any of the excipients.


Side Effects

There may be hypoglycaemia, nasopharyngitis, hack and pancreatitis in combination with metformin and sulfonylurea.


Pregnancy & Lactation

Pregnancy category B. There are no satisfactory and well controlled ponders in pregnant ladies. So, Linagliptin tablets ought to be utilized amid pregnancy as it were in case clearly required. It isn’t known whether Linagliptin passes into breast drain or not.


Precautions & Warnings

Hypersensitivity to the dynamic substance or to any of the excipients.


Therapeutic Class

Dipeptidyl Peptidase-4 (DPP-4) inhibitor


Storage Conditions

Keep in a dry place absent from light and warm. Keep out of the reach of children.


Pharmaceutical Name

Drug International Ltd.